UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000053743
Receipt number R000061334
Scientific Title Relationship between autonomic nerve function and paralyzed upper limb function in convalescent stroke rehabilitation patients -A preliminary study
Date of disclosure of the study information 2024/03/01
Last modified on 2025/09/01 09:46:40

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Evaluation of autonomic nervous system function in stroke patients

Acronym

Evaluation of autonomic nervous system function in stroke patients

Scientific Title

Relationship between autonomic nerve function and paralyzed upper limb function in convalescent stroke rehabilitation patients -A preliminary study

Scientific Title:Acronym

Relationship between autonomic nerve function and paralyzed upper limb function in convalescent stroke rehabilitation patients -A preliminary study

Region

Japan


Condition

Condition

stroke

Classification by specialty

Rehabilitation medicine

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

The purpose of this study is to examine the relationship between changes in heart rate variability and upper extremity motor function during upper extremity functional assessment and at rest.

Basic objectives2

Others

Basic objectives -Others

The purpose of this study is to examine the relationship between changes in heart rate variability and upper extremity motor function during upper extremity functional assessment and at rest

Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Fugl-Meyer Assessment(Upper extremity)

Key secondary outcomes

Grip power, Modified Ashworth Scale, Box and Block test


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Device,equipment

Interventions/Control_1

ECG to evaluate autonomic function

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1) Patients with cerebral infarction and cerebral hemorrhage (excluding subarachnoid hemorrhage)
2) Patients who are hospitalized for first-ever stroke and have no recurrence, (excluding those who have no symptoms and were found incidentally on imaging tests).
3) Patients with unilateral cerebral hemispheric lesion
4) Patients over 20 years old
5) Patients who were admitted to this hospital within 2 months after the onset of the stroke
6) Patients undergoing convalescent rehabilitation
7) Patients with SIAS (Stroke Impairment Assessment Set) knee-mouth test of 1 or more and finger-function test of 1a or more.
8) Patients with MMSE of 24 points or more at the time of admission
9) Patients who can be evaluated for upper limb function in a sitting position

Key exclusion criteria

1) Patients with a history of arrhythmia
2) Patients with a history of heart, aortic or carotid artery surgery
3) Patients with severe complications
4) Patients with a history of trauma, surgery, or disease that may affect the movement of the paralyzed upper limb
5) Patients with a history of neurological disease
6) Patients with suspected diabetic neuropathy
7) Patients who are taking beta blockers
8) Patients with higher brain dysfunction such as aphasia or somatoform apraxia who cannot follow movement instructions
9) Other patients deemed ineligible as subjects by the attending physician

Target sample size

10


Research contact person

Name of lead principal investigator

1st name Masahiro
Middle name
Last name Tsujikawa

Organization

Tokyo Bay Rehabilitation Hospital

Division name

Department of Rehabilitation Medicine

Zip code

275-0026

Address

4-1-1 Yatsu, Narashino-shi, Chiba, Japan

TEL

047-453-9000

Email

tsujikawa-ma@hotmail.co.jp


Public contact

Name of contact person

1st name Masahiro
Middle name
Last name Tsujikawa

Organization

Tokyo Bay Rehabilitation Hospital

Division name

Department of Rehabilitation Medicine

Zip code

275-0026

Address

4-1-1 Yatsu, Narashino-shi, Chiba, Japan

TEL

047-453-9000

Homepage URL


Email

tsujikawa-ma@hotmail.co.jp


Sponsor or person

Institute

Tokyo Bay Rehabilitation Hospital

Institute

Department

Personal name



Funding Source

Organization

Tokyo Bay Rehabilitation Hospital

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Tokyo Bay Rehabilitation Hospital

Address

4-1-1 Yatsu, Narashino-shi, Chiba

Tel

047-453-9000

Email

shinsakai@wanreha.net


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2024 Year 03 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

4

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Terminated

Date of protocol fixation

2023 Year 12 Month 20 Day

Date of IRB

2024 Year 02 Month 28 Day

Anticipated trial start date

2024 Year 03 Month 04 Day

Last follow-up date

2025 Year 09 Month 30 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2024 Year 03 Month 01 Day

Last modified on

2025 Year 09 Month 01 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000061334